Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt issuances (2018 - 2025)

Historic Short-Term Debt issuances for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Q3 2025 value amounting to $172000.0.

  • Amphastar Pharmaceuticals' Short-Term Debt issuances fell 9819.1% to $172000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 2126.57%. This contributed to the annual value of $18.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Short-Term Debt issuances is $172000.0, which was down 9819.1% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Short-Term Debt issuances peaked at $500.0 million during Q2 2023, and registered a low of -$25000.0 during Q2 2024.
  • For the 3-year period, Amphastar Pharmaceuticals' Short-Term Debt issuances averaged around $65.5 million, with its median value being $4.1 million (2024).
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Short-Term Debt issuances crashed by 10000.5% in 2024, and later soared by 1661600.0% in 2025.
  • Amphastar Pharmaceuticals' Short-Term Debt issuances (Quarter) stood at $500.0 million in 2023, then plummeted by 99.03% to $4.9 million in 2024, then crashed by 96.47% to $172000.0 in 2025.
  • Its last three reported values are $172000.0 in Q3 2025, $4.1 million for Q2 2025, and $1.6 million during Q1 2025.